Endocrine therapy for breast cancer

VCCC Alliance Breast Cancer Education Series

What you will learn

Leading experts share complex management strategies to help patients going through endocrine therapy.

Presenters will review the impact and management of a diagnosis and how it affects menopause, with real case presentations.

Menopause is a common side effect of endocrine therapy and drugs such as tamoxifen can supress ovary function in premenopausal women. Having a confident grasp on identifying side effects and strategies for management are important for all clinicians across the multidisciplinary breast cancer spectrum.

Aim: To review the impact and management of a diagnosis and how it affects menopause. 

Learning Objective: To discuss complex management strategies to help patients going through endocrine therapy. 

The VCCC Alliance Breast Cancer Education Series is targeted at a clinical audience and features open discussion about real cases and patients. While these cases are de-identified, the imagery, content and discussion can be graphic. It is not appropriate for consumer participants.

Additional information

Facilitated by

Dr Belinda Yeo
VCCC Alliance, Breast Cancer Research & Education Lead
Medical Oncologist, Austin Health

Professor Bruce Mann
VCCC Alliance, Breast Cancer Research & Education Lead
Director, Breast Cancer Services, The Royal Melbourne Hospital and Royal Women's Hospital